News Releases

PHOENIX, Ariz., March 5, 2020 — SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, today announced that it has entered into a definitive agreement with an institutional investor for the purchase and sale of 176,372 shares of SenesTech’s common stock, at a purchase price of $3.005 per share, for gross proceeds of approximately $0.5 million in a registered direct offering priced at-the-market. SenesTech has also agreed to issue to the investor unregistered warrants to purchase up to an aggregate of 176,372 shares of common stock. The closing of the offering is expected to occur on or about March 9, 2020, subject to the satisfaction of customary closing conditions.

H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.

The warrants have an exercise price of $2.88 per share of common stock, will be exercisable immediately following the date of issuance and will expire five and one-half years following the date of issuance.

SenesTech currently intends to use the net proceeds from the offering for working capital and other general corporate purposes.

The shares of common stock (but not the warrants or the shares of common stock underlying the warrants) are being offered by SenesTech pursuant to a “shelf” registration statement on Form S-3 previously filed with the Securities and Exchange Commission (the “SEC”) on June 19, 2018, as amended, and declared effective by the SEC on August 24, 2018. A prospectus supplement and accompanying prospectus relating to the shares of common stock being offered will be filed with the SEC. Electronic copies of the prospectus supplement and accompanying prospectus may be obtained, when available, on the SEC’s website at http://www.sec.gov or by contacting H.C. Wainwright & Co., LLC at 430 Park Avenue, 3rd Floor, New York, NY 10022, by phone at (646) 975-6996 or e-mail at placements@hcwco.com.

The warrants described above were offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Act”), and Regulation D promulgated thereunder and, along with the shares of common stock underlying the warrants, have not been registered under the Act, or applicable state securities laws. Accordingly, the warrants and underlying shares of common stock may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Act and such applicable state securities laws.